ReviewDrug design, development and therapy2016

Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.

Maryam Abbaspour Babaei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.